Caribou Biosciences Inc (CRBU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 3,502 | 3,692 | 3,303 | 4,192 | 2,664 |
| Gross Profit | 3,502 | 3,692 | 3,303 | 4,192 | 2,664 |
| Operating Expenses | 34,618 | 34,270 | 29,840 | 32,623 | 23,517 |
| Operating Income | -31,116 | -30,578 | -26,537 | -28,431 | -20,853 |
| Other Income | 3,072 | 3,659 | -110 | 1,734 | 1,765 |
| Pre-tax Income | -28,044 | -26,919 | -26,647 | -26,697 | -19,088 |
| Net Income Continuous | -28,044 | -26,989 | -26,647 | -26,697 | -19,088 |
| Net Income | $-28,044 | $-26,989 | $-26,647 | $-26,697 | $-19,088 |
| EPS Basic Total Ops | -0.46 | -0.44 | -0.44 | -0.44 | -0.32 |
| EPS Basic Continuous Ops | -0.46 | -0.44 | -0.44 | -0.44 | -0.32 |
| EPS Diluted Total Ops | -0.46 | -0.44 | -0.44 | -0.44 | -0.32 |
| EPS Diluted Continuous Ops | -0.46 | -0.44 | -0.44 | -0.44 | -0.32 |
| EBITDA(a) | $-32,021 | $-30,975 | $-26,430 | $-27,951 | $-20,218 |